Published in PLoS One on November 08, 2013
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem Rev (1999) 12.52
The Rician distribution of noisy MRI data. Magn Reson Med (1995) 10.10
A modular system for the synthesis of multiplexed magnetic resonance probes. J Am Chem Soc (2011) 1.40
Modeling the space of camera response functions. IEEE Trans Pattern Anal Mach Intell (2004) 1.28
A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage (2008) 1.20
Biosensors and biochips: advances in biological and medical diagnostics. Fresenius J Anal Chem (2001) 1.19
High-performance nanostructured MR contrast probes. Nanoscale (2010) 0.98
Automated MR image synthesis: feasibility studies. Radiology (1984) 0.95
Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging. MRS Bull (2009) 0.95
Eigenimage filtering in MR imaging. J Comput Assist Tomogr (1988) 0.95
Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging. Contrast Media Mol Imaging (2013) 0.91
Imaging apolipoprotein AI in vivo. NMR Biomed (2011) 0.88
The utility of principal component analysis for the image display of brain lesions. A preliminary, comparative study. Magn Reson Med (1987) 0.88
Modified lipoproteins as contrast agents for imaging of atherosclerosis. Contrast Media Mol Imaging (2007) 0.86
Automatic high-dynamic range image generation for dynamic scenes. IEEE Comput Graph Appl (2008) 0.86
Magnetic resonance image synthesis using a flexible model. Br J Radiol (1994) 0.84
Highly dispersible, superparamagnetic magnetite nanoflowers for magnetic resonance imaging. Chem Commun (Camb) (2009) 0.84
Molecular imaging of in vivo gene expression. Future Med Chem (2010) 0.84
The contrast-to-noise in relaxation time, synthetic, and weighted-sum MR images. Magn Reson Med (1987) 0.82
CNR enhancement in the presence of multiple interfering processes using linear filters. Magn Reson Med (1990) 0.80
Target-point combination of MR images. Magn Reson Med (1991) 0.80
Reviewing state-of-art imaging modalities and its potential for biomedical applications. J Dent (2009) 0.79
Synthetic-echo time postprocessing technique for generating images with variable T2-weighted contrast: diagnosis of meniscal and cartilage abnormalities of the knee. Radiology (2010) 0.79
Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med (2013) 1.99
Bioresponsive, cell-penetrating, and multimeric MR contrast agents. Acc Chem Res (2009) 1.94
Multimodal MRI contrast agents. J Biol Inorg Chem (2007) 1.86
Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage (2004) 1.86
Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage (2002) 1.82
The synthesis and in vitro testing of a zinc-activated MRI contrast agent. Proc Natl Acad Sci U S A (2007) 1.65
Mechanistic studies of a calcium-dependent MRI contrast agent. Inorg Chem (2002) 1.64
Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents. Nano Lett (2005) 1.59
Gd(III)-nanodiamond conjugates for MRI contrast enhancement. Nano Lett (2010) 1.50
Synthesis of multimeric MR contrast agents for cellular imaging. J Am Chem Soc (2008) 1.49
Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging. Angew Chem Int Ed Engl (2009) 1.47
PSA enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness. Prostate (2013) 1.43
A modular system for the synthesis of multiplexed magnetic resonance probes. J Am Chem Soc (2011) 1.40
Lanthanide probes for bioresponsive imaging. Chem Rev (2013) 1.34
Magnetic resonance imaging of self-assembled biomaterial scaffolds. Bioconjug Chem (2005) 1.29
Mechanistic investigation of beta-galactosidase-activated MR contrast agents. Inorg Chem (2007) 1.24
The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry. NMR Biomed (2007) 1.23
Cellular delivery of MRI contrast agents. Chem Biol (2004) 1.20
DNA-TiO2 nanoconjugates labeled with magnetic resonance contrast agents. J Am Chem Soc (2007) 1.19
Reporter protein-targeted probes for magnetic resonance imaging. J Am Chem Soc (2011) 1.18
A gadolinium chelate for detection of beta-glucuronidase: a self-immolative approach. J Am Chem Soc (2005) 1.16
Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co(III) Schiff base conjugate. Proc Natl Acad Sci U S A (2009) 1.15
Mechanisms of ZnII-activated magnetic resonance imaging agents. Inorg Chem (2008) 1.14
Targeted inactivation of Snail family EMT regulatory factors by a Co(III)-Ebox conjugate. PLoS One (2012) 1.05
Quantitative imaging of cell-permeable magnetic resonance contrast agents using x-ray fluorescence. Mol Imaging (2006) 1.04
Analytical methods for characterizing magnetic resonance probes. Anal Chem (2012) 1.03
Specific inhibition of the transcription factor Ci by a cobalt(III) Schiff base-DNA conjugate. Mol Pharm (2012) 1.03
A templating approach for monodisperse self-assembled organic nanostructures. J Am Chem Soc (2008) 1.02
Electrochemistry of redox-active self-assembled monolayers. Coord Chem Rev (2010) 1.02
A steroid-conjugated magnetic resonance probe enhances contrast in progesterone receptor expressing organs and tumors in vivo. Mol Pharm (2011) 1.02
Rational design, synthesis, and biological evaluation of progesterone-modified MRI contrast agents. Chem Biol (2007) 1.01
High-performance nanostructured MR contrast probes. Nanoscale (2010) 0.98
Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release. Angew Chem Int Ed Engl (2010) 0.98
Synthesis and visualization of a membrane-permeable MRI contrast agent. J Biol Inorg Chem (2003) 0.97
Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging. MRS Bull (2009) 0.95
Use of a genetically engineered protein for the design of a multivalent MRI contrast agent. Bioconjug Chem (2007) 0.94
Cell-permeable MR contrast agents with increased intracellular retention. Bioconjug Chem (2008) 0.94
Multivalent protein polymer MRI contrast agents: controlling relaxivity via modulation of amino acid sequence. Biomacromolecules (2010) 0.94
Preparation of magnetic resonance contrast agents activated by beta-galactosidase. Nat Protoc (2008) 0.93
Synthesis and biological evaluation of water-soluble progesterone-conjugated probes for magnetic resonance imaging of hormone related cancers. Bioconjug Chem (2011) 0.92
Cell labeling via membrane-anchored lipophilic MR contrast agents. Bioconjug Chem (2014) 0.92
Graphene oxide enhances cellular delivery of hydrophilic small molecules by co-incubation. ACS Nano (2014) 0.92
Receptor mediated uptake of a radiolabeled contrast agent sensitive to beta-galactosidase activity. Nucl Med Biol (2003) 0.91
Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex. J Biol Inorg Chem (2012) 0.90
A steroid-conjugated contrast agent for magnetic resonance imaging of cell signaling. J Am Chem Soc (2005) 0.90
Cobalt derivatives as promising therapeutic agents. Curr Opin Chem Biol (2012) 0.89
Axial ligand exchange of N-heterocyclic cobalt(III) Schiff base complexes: molecular structure and NMR solution dynamics. Inorg Chem (2013) 0.88
Mirror image nanostructures. J Am Chem Soc (2005) 0.88
Protein polymer MRI contrast agents: Longitudinal analysis of biomaterials in vivo. Magn Reson Med (2011) 0.88
Mechanisms of Gadographene-Mediated Proton Spin Relaxation. J Phys Chem C Nanomater Interfaces (2013) 0.88
Magnetic resonance contrast agents for medical and molecular imaging. Met Ions Biol Syst (2004) 0.87
A novel mouse model that develops spontaneous arthritis and is predisposed towards atherosclerosis. Ann Rheum Dis (2012) 0.87
Chemistry of molecular imaging. Acc Chem Res (2009) 0.86
Modification of embolic-PVA particles with MR contrast agents. Magn Reson Med (2008) 0.86
Probing the Chemical Stability of Mixed Ferrites: Implications for MR Contrast Agent Design. Chem Mater (2011) 0.85
Highly dispersible, superparamagnetic magnetite nanoflowers for magnetic resonance imaging. Chem Commun (Camb) (2009) 0.84
Synthesis and characterization of a doxorubicin-Gd(III) contrast agent conjugate: a new approach toward prodrug-procontrast complexes. Inorg Chem (2006) 0.84
Molecular imaging of in vivo gene expression. Future Med Chem (2010) 0.84
Spectroscopic elucidation of the inhibitory mechanism of Cys2His2 zinc finger transcription factors by cobalt(III) Schiff base complexes. Chemistry (2013) 0.84
Multimodal imaging enables early detection and characterization of changes in tumor permeability of brain metastases. J Control Release (2013) 0.83
Rational design of [Co(acacen)L2]+ inhibitors of protein function. Dalton Trans (2013) 0.83
Structural optimization of Zn(II)-activated magnetic resonance imaging probes. Inorg Chem (2013) 0.83
Kinetic dispersion in redox-active dithiocarbamate monolayers. Langmuir (2010) 0.82
Synapse-binding subpopulations of Aβ oligomers sensitive to peptide assembly blockers and scFv antibodies. ACS Chem Neurosci (2012) 0.82
Advances and innovations in brain arteriovenous malformation surgery. Neurosurgery (2014) 0.82
Chiral porphyrazine near-IR optical imaging agent exhibiting preferential tumor accumulation. Proc Natl Acad Sci U S A (2009) 0.82
Gd(III)-labeled peptide nanofibers for reporting on biomaterial localization in vivo. ACS Nano (2014) 0.81
A multimeric MR-optical contrast agent for multimodal imaging. Chem Commun (Camb) (2014) 0.81
Theranostic Magnetic Nanostructures (MNS) for Cancer. Cancer Treat Res (2015) 0.81
High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation. ACS Nano (2015) 0.81
Synthesis and characterization of new porphyrazine-Gd(III) conjugates as multimodal MR contrast agents. Bioconjug Chem (2010) 0.81
Synthesis, Characterization, and in vitro Testing of a Bacteria-Targeted MR Contrast Agent. Eur J Inorg Chem (2012) 0.81
Liver cell labelling with MRI contrast agents. Methods Mol Biol (2009) 0.80
Photoinduced electron transfer from PbS quantum dots to cobalt(III) Schiff base complexes: light activation of a protein inhibitor. J Am Chem Soc (2013) 0.80
Pillar[5]arene as a co-factor in templating rotaxane formation. J Am Chem Soc (2013) 0.80
Synthesis and characterization of a porphyrazine-Gd(III) MRI contrast agent and in vivo imaging of a breast cancer xenograft model. Contrast Media Mol Imaging (2014) 0.80
Electroactive self-assembled monolayers on gold via bipodal dithiazepane anchoring groups. Langmuir (2008) 0.79
Ferrocene and maleimide-functionalized disulfide scaffolds for self-assembled monolayers on gold. Org Lett (2010) 0.79
Synthesis and electrochemical characterization of a transition-metal-modified ligand-receptor pair. J Am Chem Soc (2005) 0.78
Polystyrene microsphere-ferritin conjugates: a robust phantom for correlation of relaxivity and size distribution. Magn Reson Med (2010) 0.78
Extending the distance range accessed with continuous wave EPR with Gd3+ spin probes at high magnetic fields. Phys Chem Chem Phys (2013) 0.78
Progesterone-targeted magnetic resonance imaging probes. Bioconjug Chem (2014) 0.77
Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complex. J Am Chem Soc (2015) 0.77
Protein binding and the electronic properties of iron(II) complexes: an electrochemical and optical investigation of outer sphere effects. Bioconjug Chem (2009) 0.76
A Three-Channel Spectrometer for Wide-Field Imaging of Anisotropic Plasmonic Nanoparticles. J Phys Chem C Nanomater Interfaces (2011) 0.76
Spectroscopic and redox properties of amine-functionalized K2[OsII(bpy)(CN)4] complexes. Dalton Trans (2011) 0.76
Modulation of amyloid-β aggregation by histidine-coordinating Cobalt(III) Schiff base complexes. Chembiochem (2014) 0.76
5' modification of duplex DNA with a ruthenium electron donor-acceptor pair using solid-phase DNA synthesis. Inorg Chem (2003) 0.76
Trinuclear ruthenium clusters as bivalent electrochemical probes for ligand-receptor binding interactions. Langmuir (2011) 0.75
Water-soluble lipophilic MR contrast agents for cell membrane labeling. J Biol Inorg Chem (2015) 0.75
Maximizing Magnetic Resonance Contrast in Gd(III) Nanoconjugates: Investigation of Proton Relaxation in Zirconium Metal-Organic Frameworks. ACS Appl Mater Interfaces (2020) 0.75
Synthesis and characterization of ruthenium and rhenium nucleosides. Inorg Chem (2007) 0.75
Targeted Radiosensitizers for MR-Guided Radiation Therapy of Prostate Cancer. Nano Lett (2020) 0.75
2'-modified nucleosides for site-specific labeling of oligonucleotides. Bioconjug Chem (2002) 0.75
Correction to Gd(III)-Labeled Peptide Nanofibers for Reporting on Biomaterial Localization in Vivo. ACS Nano (2015) 0.75
Preface for the forum on metals in medicine and health: new opportunities and approaches to improving health. Inorg Chem (2013) 0.75